Catalyst Pharmaceuticals, Inc. (CPRX)

Catalyst Pharmaceuticals Revenue

Catalyst Pharmaceuticals had revenue of $149.39M in the quarter ending March 31, 2026, with 5.63% growth. This brings the company's revenue in the last twelve months to $596.96M, up 11.65% year-over-year. In the year 2025, Catalyst Pharmaceuticals had annual revenue of $588.99M with 19.78% growth.

• Revenue (ttm): $596.96M
• Revenue Growth: +11.65%
• P/S Ratio: 6.39
• Revenue / Employee: $3,279,989
• Employees: 182
• Market Cap: 3.82B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	588.99M	97.26M	19.78%
Dec 31, 2024	491.73M	93.53M	23.49%
Dec 31, 2023	398.20M	184.00M	85.90%
Dec 31, 2022	214.20M	73.37M	52.10%
Dec 31, 2021	140.83M	21.76M	18.27%
Dec 31, 2020	119.07M	16.77M	16.39%
Dec 31, 2019	102.31M	101.81M	20,361.20%
Dec 31, 2018	500.00K	-	-
Dec 31, 2017	-	-	-
Dec 31, 2016	-	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-
Dec 31, 2010	488.96K	-	-
Dec 31, 2009	-	-	-
Dec 31, 2008	-	-	-
Dec 31, 2007	-	-	-
Dec 31, 2006	-	-	-
Dec 31, 2005	-	-	-

Data Source: Fiscal.ai Last updated: May 11, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error